CDEK
← All trials

NCT06749054

Phase 2Interventional

Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jan 31, 2025
Primary completion
Mar 31, 2026
Completion date
Aug 31, 2026
First posted
Dec 27, 2024
Last posted
Dec 27, 2024
Enrollment
12
Arms / groups
1 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.